4
Changes in Ownership
BioAge Labs, Inc. Filed Acc 0001415889-25-004859
Options or other derivatives
- Chief Financial Officer acquired 170,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GOLDSTEIN DOV A MD Chief Financial Officer | 2025-02-18 | Grant or award · Stock Option (Right to Buy) | +170,000 | 170,000 | D: show line 1 in the form |
Loading xslF345X05/form4-02202025_090258.xml…